论文部分内容阅读
目的:分析探究阿奇霉素对呼吸道感染的临床疗效及药理特性。方法:将180例呼吸道感染患者随机分为观察组和对照组,每组各90例患者,观察组患者采用阿奇霉素进行治疗,对照组患者采用红霉素进行治疗,分析两组患者的临床治疗效果以及治疗期间不良症状的发生情况。结果:观察组患者治疗后,总有效率为96.7%,高于对照组患者的81.1%,差异显著(P<0.05);且观察组患者的不良症状发生率远低于对照组患者,差异显著(P<0.05)。结论:阿奇霉素对呼吸道感染的治疗效果显著,有细菌对该药的耐药性低,抗菌杀菌效果显著,不良症状较少的药理特性。
Objective: To analyze the clinical effect and pharmacological characteristics of azithromycin on respiratory tract infection. Methods: 180 patients with respiratory tract infection were randomly divided into observation group and control group, each group of 90 patients, the observation group were treated with azithromycin, the control group of patients treated with erythromycin, analysis of two groups of patients with clinical treatment As well as the occurrence of adverse symptoms during treatment. Results: After treatment, the total effective rate was 96.7% in the observation group, which was significantly higher than that in the control group (81.1%) (P <0.05). The incidence of adverse symptoms in the observation group was much lower than that in the control group (P <0.05). Conclusion: Azithromycin has a significant therapeutic effect on respiratory tract infections. The antibacterial properties of azithromycin are low, antibacterial and bactericidal effect are obvious, and the adverse symptoms are few.